U
Australis Capital Inc. AUSAF
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Australis Capital Inc. is a Canada-based investment and operating company focused primarily on the cannabis industry and adjacent sectors in North America. The company has historically operated through a combination of direct ownership interests, strategic investments, intellectual property development, and operating subsidiaries tied to cultivation, manufacturing, distribution, and cannabis-related technologies. Australis Capital has traded publicly under the ticker AUSAF in the United States over-the-counter market and has also been listed in Canada through the Canadian Securities Exchange. Public filings and corporate disclosures identify the company as operating within the regulated cannabis, wellness, and alternative investment sectors.

The company’s business model has evolved from a cannabis-focused investment platform into a broader operating and asset-management structure centered on strategic holdings and operational partnerships. Revenue generation has historically depended on operating subsidiaries, licensing arrangements, and investment-related activities tied to cannabis infrastructure and consumer products. Australis Capital has sought to position itself through early-stage exposure to regulated cannabis markets, particularly in the United States, while maintaining flexibility through portfolio investments and asset acquisitions. Publicly available information indicates that the company has periodically restructured assets and strategy in response to changing cannabis market conditions and capital availability.

Business Operations

Australis Capital’s operations have included ownership stakes and operational involvement in cannabis cultivation, manufacturing, retail, and related technologies. The company has previously reported activities tied to subsidiaries and portfolio investments including ALPS, Green Therapeutics, and other cannabis-related operating assets disclosed in corporate filings and investor materials. The company has also pursued opportunities involving intellectual property, automated cultivation technologies, and cannabinoid product development. Revenue has historically been generated through subsidiary operations, product sales, licensing activities, and investment holdings.

The company’s operational footprint has primarily centered on the United States cannabis market, with emphasis on regulated state-level jurisdictions such as Nevada and California. Australis Capital has also maintained corporate connections to Canada through its public listing and corporate structure. Public disclosures indicate that the company has engaged in strategic partnerships, financing arrangements, and acquisitions intended to expand operational capacity and market access. Some historical investments and partnerships have undergone restructuring, divestiture, or impairment as broader cannabis industry conditions weakened. Certain operational details and current asset performance remain difficult to independently verify through recent public disclosures, and some data is inconclusive based on available public sources.

Strategic Position & Investments

Australis Capital’s strategic direction has generally focused on building exposure to high-growth cannabis and cannabis-adjacent businesses while leveraging capital allocation and operational partnerships. The company has pursued acquisitions and investments intended to create vertically integrated capabilities across cultivation, manufacturing, distribution, and consumer products. Public filings and investor communications have referenced strategic investments in cannabis technologies, brand development, and production infrastructure designed to support long-term participation in the regulated cannabis economy.

The company has also explored opportunities tied to automation, intellectual property, and emerging product categories connected to cannabinoids and wellness applications. Historical acquisitions and investments have included interests in Green Therapeutics, along with other operating entities and portfolio holdings disclosed in corporate reports. Australis Capital’s strategic positioning has been influenced heavily by broader cannabis sector volatility, regulatory uncertainty in the United States, and capital market conditions affecting cannabis operators. Available public information indicates that management has periodically adjusted strategy toward operational efficiency, restructuring initiatives, and selective asset monetization.

Geographic Footprint

Australis Capital maintains corporate roots in Canada while concentrating much of its operational activity in the United States cannabis market. The company’s business activities and investments have historically been concentrated in Nevada, with additional exposure to other regulated U.S. jurisdictions including California. Public disclosures indicate that the company has pursued opportunities in multiple North American cannabis markets through investments, partnerships, and subsidiary operations.

The company’s international presence has primarily been linked to its Canadian corporate structure and public market participation rather than large-scale direct overseas operations. Australis Capital’s influence outside North America appears limited based on available public records. While the company has discussed broader industry opportunities tied to global cannabis liberalization trends, independently verifiable evidence of significant operational activity beyond North America remains limited.

Leadership & Governance

Australis Capital was formed during the expansion phase of the North American cannabis industry and has undergone multiple leadership and governance changes over time. Public company filings identify a management team with backgrounds spanning cannabis operations, finance, investment management, and corporate development. Leadership strategy has generally emphasized disciplined capital allocation, strategic investments, and operational scalability within regulated cannabis markets.

Key executives and directors identified in public disclosures include:

  • Jon Paul – Chief Executive Officer
  • Duke Fu – Chief Financial Officer
  • Scott Dowty – Executive Vice President of Operations
  • Terry Booth – Founder and former strategic figure associated with the company’s early development

The company’s governance approach has emphasized strategic flexibility and opportunistic investment activity within emerging regulated industries. However, management turnover and periodic restructuring activity have also been noted in public filings and investor communications. Certain leadership roles and executive appointments may have changed over time, and some current governance data is inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $214.72
B
AAPL NASDAQ $309.35
B
AVGO NASDAQ $368.45
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $103.70
Top Financial Stocks
See All »
B
B
JPM NYSE $351.58
B
V NYSE $371.04
Top Health Care Stocks
See All »
B
LLY NYSE $1,255.40
B
JNJ NYSE $270.24
B
ABBV NYSE $264.96
Top Real Estate Stocks
See All »
B
PLD NYSE $141.80
B
EQIX NASDAQ $1,065.39